Person

Cathy R. Smith

Director, Boston Scientific

Current S&P 500 boards
2
Current roles
3
Open-market buys
$634K
Open-market sales
$4.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 23, 2019TGTSale8,412$104.40$878K
Apr 11, 2019TGTSale20,000$80.83$1.6M
Mar 1, 2019TGTSale30,000$74.00$2.2M
Mar 1, 2017TGTBuy5,000$58.95$295K
May 20, 2016TGTBuy5,000$67.82$339K

SEC reporting-owner ID (CIK) 1322028 · all filings on EDGAR